Australia markets closed

Viridian Therapeutics, Inc. (VRDN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
12.88+0.18 (+1.42%)
At close: 04:00PM EDT
12.88 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-237,734
-237,734
-129,874
-79,413
-110,715
Depreciation & amortisation
522
522
255
120
239
Stock-based compensation
67,172
67,172
19,765
14,465
3,645
Change in working capital
-9,425
-9,425
15,962
1,724
4,427
Accounts receivable
-
-
-
-
99
Accounts payable
-12,040
-12,040
11,524
1,655
-426
Other working capital
-185,068
-185,068
-94,635
-54,919
-29,821
Other non-cash items
6,603
6,603
264
7,485
72,569
Net cash provided by operating activities
-184,170
-184,170
-93,838
-54,581
-29,779
Cash flows from investing activities
Investments in property, plant and equipment
-898
-898
-797
-338
-42
Purchases of investments
-407,880
-407,880
-223,264
-188,431
-81,807
Sales/maturities of investments
314,526
314,526
108,935
114,398
2,000
Other investing activities
-
-
-
-
-3
Net cash used for investing activities
-94,252
-94,252
-115,126
-74,292
-50,481
Cash flows from financing activities
Debt repayment
-
-
-
0
-10,293
Common stock issued
125,069
125,069
291,874
114,242
25,104
Other financing activities
-12,315
-12,315
-22,510
-8,278
-6,223
Net cash used provided by (used for) financing activities
225,670
225,670
322,244
125,275
101,311
Net change in cash
-52,752
-52,752
113,280
-3,598
21,051
Cash at beginning of period
155,579
155,579
42,299
45,897
24,846
Cash at end of period
102,827
102,827
155,579
42,299
45,897
Free cash flow
Operating cash flow
-184,170
-184,170
-93,838
-54,581
-29,779
Capital expenditure
-898
-898
-797
-338
-42
Free cash flow
-185,068
-185,068
-94,635
-54,919
-29,821